£30m Initiative to Tackle deadly AMR Threat

The UK's largest public-private initiative targeting early-stage antimicrobial drug and diagnostic discovery has been introduced by Innovate UK, LifeArc and Medicines Discovery Catapult (MDC). Click to read more...

Related Keywords

United Kingdom ,Paula Sommer ,Dame Sally Davies ,Ron Daniels ,Indro Mukerjee ,Chris Molloy ,Department For Science ,World Bank ,Head Of Research At Cystic Fibrosis ,United Kingdom Sepsis ,Innovate United Kingdom ,Medicines Discovery Catapult ,Antimicrobial Clinical Efficacy ,United Kingdom Special Envoy ,Antimicrobial Resistance ,Life Arc ,George Freeman ,United Kingdom Sepsis Trust ,Cystic Fibrosis Trust ,Medicines Discovery ,Discovery Catapult ,Discovery ,Race ,Health ,Antimicrobial ,Lobal ,Dash ,Oday ,Resistant ,Infections ,Resistance ,